Australia markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.49-0.45 (-2.82%)
At close: 04:00PM EDT
15.40 -0.09 (-0.58%)
After hours: 04:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.53B
Enterprise value 1.45B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.19
Price/book (mrq)19.55
Enterprise value/revenue 26.22
Enterprise value/EBITDA -6.43

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 311.78%
S&P500 52-week change 326.36%
52-week high 319.09
52-week low 39.50
50-day moving average 316.89
200-day moving average 313.85

Share statistics

Avg vol (3-month) 31.3M
Avg vol (10-day) 31.58M
Shares outstanding 596.12M
Implied shares outstanding 696.12M
Float 895.38M
% held by insiders 14.71%
% held by institutions 174.66%
Shares short (30 Apr 2024) 44.8M
Short ratio (30 Apr 2024) 45.23
Short % of float (30 Apr 2024) 45.69%
Short % of shares outstanding (30 Apr 2024) 44.99%
Shares short (prior month 28 Mar 2024) 410.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -284.42%
Operating margin (ttm)-95.79%

Management effectiveness

Return on assets (ttm)-54.91%
Return on equity (ttm)-779.92%

Income statement

Revenue (ttm)55.14M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -133.87M
Net income avi to common (ttm)-156.83M
Diluted EPS (ttm)-1.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.79M
Total cash per share (mrq)0.92
Total debt (mrq)36.73M
Total debt/equity (mrq)46.87%
Current ratio (mrq)2.85
Book value per share (mrq)0.82

Cash flow statement

Operating cash flow (ttm)-127.98M
Levered free cash flow (ttm)-118M